Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, talks about the importance of conducting regular evaluations to ensure that prescribing the most cost-effective option, whether that be a biosimilar or the reference product.
Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, talks about the importance of conducting regular evaluations to ensure that prescribing the most cost-effective option, whether that be a biosimilar or the reference product.
Transcript:
Could you explain some of the price declines that we've seen among oncology biosimilars and the significance of this?
Yeah, it's so important to measure. So, we switched our patients that were on Procrit [epoetin alfa] over to the biosimilar because of the cost savings. But it's important to realize that you do need to reevaluate where you are with which product that you're using because the prices can change. And so, just because it's a biosimilar and maybe when it was first released, it was the lowest cost product, that doesn't mean that it's going to stay that way.
Even the prices of the [reference] drugs are coming down. So, it's important to reevaluate that from time to time, whatever your cadence is, to ensure that what you're using is still actually cost-effective and that you're not actually increasing cost of care.
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More